183 related articles for article (PubMed ID: 9870919)
1. Recombinant human Monocyte/Neutrophil elastase inhibitor protects rat lungs against injury from cystic fibrosis airway secretions.
Rees DD; Rogers RA; Cooley J; Mandle RJ; Kenney DM; Remold-O'Donnell E
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):69-78. PubMed ID: 9870919
[TBL] [Abstract][Full Text] [Related]
2. Protection against acute lung injury by intravenous or intratracheal pretreatment with EPI-HNE-4, a new potent neutrophil elastase inhibitor.
Delacourt C; Hérigault S; Delclaux C; Poncin A; Levame M; Harf A; Saudubray F; Lafuma C
Am J Respir Cell Mol Biol; 2002 Mar; 26(3):290-7. PubMed ID: 11867337
[TBL] [Abstract][Full Text] [Related]
3. Effects of cystic fibrosis airway secretions on rat lung: role of neutrophil elastase.
Rees DD; Brain JD
Am J Physiol; 1995 Aug; 269(2 Pt 1):L195-202. PubMed ID: 7653580
[TBL] [Abstract][Full Text] [Related]
4. Production of recombinant human monocyte/neutrophil elastase inhibitor (rM/NEI).
Cooley J; Mathieu B; Remold-O'Donnell E; Mandle RJ
Protein Expr Purif; 1998 Oct; 14(1):38-44. PubMed ID: 9758749
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of neutrophil elastase in CF sputum by L-658,758.
Rees DD; Brain JD; Wohl ME; Humes JL; Mumford RA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1201-6. PubMed ID: 9399994
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human neutrophil elastase-induced acute lung injury in hamsters by recombinant human pre-elafin (trappin-2).
Tremblay GM; Vachon E; Larouche C; Bourbonnais Y
Chest; 2002 Feb; 121(2):582-8. PubMed ID: 11834675
[TBL] [Abstract][Full Text] [Related]
7. DNase I acutely increases cystic fibrosis sputum elastase activity and its potential to induce lung hemorrhage in mice.
Cantin AM
Am J Respir Crit Care Med; 1998 Feb; 157(2):464-9. PubMed ID: 9476859
[TBL] [Abstract][Full Text] [Related]
8. Effects of native and oxidation-resistant secretory leukoprotease inhibitor on cystic fibrosis sputum: inhibition of neutrophil elastase activity and of sputum-induced secretion from porcine tracheal submucosal glands.
Schuster A; Hansen G; Zubrod-Eichert C; Wahn V
Pediatr Res; 1996 Nov; 40(5):732-7. PubMed ID: 8910939
[TBL] [Abstract][Full Text] [Related]
9. Effects of neutrophil elastase inhibitor (ONO-5046) on lung injury after intestinal ischemia-reperfusion.
Takayama M; Ishibashi M; Ishii H; Kuraki T; Nishida T; Yoshida M
J Appl Physiol (1985); 2001 Oct; 91(4):1800-7. PubMed ID: 11568165
[TBL] [Abstract][Full Text] [Related]
10. Secretory leukocyte protease inhibitor in cystic fibrosis.
Stromatt SC
Agents Actions Suppl; 1993; 42():103-10. PubMed ID: 8102834
[TBL] [Abstract][Full Text] [Related]
11. Aerosol treatment with MNEI suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection.
Woods DE; Cantin A; Cooley J; Kenney DM; Remold-O'Donnell E
Pediatr Pulmonol; 2005 Feb; 39(2):141-9. PubMed ID: 15633200
[TBL] [Abstract][Full Text] [Related]
12. Alpha 1-proteinase inhibitor abrogates proteolytic and secretagogue activity of cystic fibrosis sputum.
Hansen G; Schuster A; Zubrod C; Wahn V
Respiration; 1995; 62(3):117-24. PubMed ID: 7569330
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil elastase and elastase-rich cystic fibrosis sputum degranulate human eosinophils in vitro.
Liu H; Lazarus SC; Caughey GH; Fahy JV
Am J Physiol; 1999 Jan; 276(1):L28-34. PubMed ID: 9887052
[TBL] [Abstract][Full Text] [Related]
14. Protease-antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions.
Hentschel J; Fischer N; Janhsen WK; Markert UR; Lehmann T; Sonnemann J; Böer K; Pfister W; Hipler UC; Mainz JG
J Cyst Fibros; 2015 May; 14(3):324-33. PubMed ID: 25286826
[TBL] [Abstract][Full Text] [Related]
15. Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity.
Vogelmeier C; Gillissen A; Buhl R
Chest; 1996 Dec; 110(6 Suppl):261S-266S. PubMed ID: 8989162
[TBL] [Abstract][Full Text] [Related]
16. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
McElvaney NG; Nakamura H; Birrer P; Hébert CA; Wong WL; Alphonso M; Baker JB; Catalano MA; Crystal RG
J Clin Invest; 1992 Oct; 90(4):1296-301. PubMed ID: 1357002
[TBL] [Abstract][Full Text] [Related]
17. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients.
Hansen G; Hoffjan S; Mosler K; Schuster A
Lung; 2001; 179(3):185-94. PubMed ID: 11891608
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis.
Martin SL; Downey D; Bilton D; Keogan MT; Edgar J; Elborn JS;
Pediatr Pulmonol; 2006 Feb; 41(2):177-83. PubMed ID: 16372352
[TBL] [Abstract][Full Text] [Related]
20. [Pretreatment of acid-induced lung injury with specific neutrophil elastase inhibitor ONO-5046 did not exasperate the subsequent bacterial lung infection by Pseudomonas aeruginosa].
Kudoh I; Miyazaki H; Yamada H; Fujimoto J; Ohara M; Tazawa T; Fukushima J; Okumura F
Masui; 2000 Jul; 49(7):724-31. PubMed ID: 10933021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]